Related Experiment Video
Updated: Jul 3, 2025

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System
Published on: July 30, 2018
SP3-induced Timeless transcription contributes to cell growth of lung adenocarcinoma cells
Ping Tian1, Dajun Du2, Li Yang3
1Medical School, Xinyang Vocational and Technical College, Xinyang, Henan, China.
Background:
Timeless is well-known for its key role in replication checkpoints. Recent studies reveal the involvement of Timeless and specificity protein (SP) 1 in human malignancies. However, no evidence proved the interaction between SP3 and Timeless in lung adenocarcinoma (LUAD).
Methods:
The expression and clinical significance of Timeless were analyzed using the LUAD dataset downloaded from the Cancer Genome Atlas (TCGA). Lentivirus-mediated Timeless knockdown in A549 cells was used to examine the role of Timeless in cell proliferation and pemetrexed (PEM) resistance. Transcription factors (TFs) bound to the Timeless promoter were identified by DNA pull-down technology with HPLC-MS/MS analysis and analyzed by the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway. Dual-luciferase reporter assay was used to determine the activity of SP3 in Timeless transcription.
Results:
Timeless was overexpressed in LUAD samples, and it could serve as a potential diagnostic or prognostic biomarker for LUAD patients. shTimeless-mediated knockdown of Timeless reduced cell viability and proliferation and sensitized PEM-resistant A549 cells to PEM. Four fragments (F1: 1-373 bp), (F2: 374-962 bp), (F4: 1274-1645 bp), and (F5: 1646-2000bp) were confirmed as the TF binding profiles of the Timeless promoter. KEGG analysis showed that the TFs bound to the Timeless promoter had relevance to spliceosome, RNA transport, and mRNA surveillance pathways. SP3 promoted the transcription of Timeless via the F2 fragment (374-962 bp) binding motif.
Conclusion:
Upregulation of Timeless mediated by SP3 promotes LUAD cell proliferation, providing evidence to support that targeting the SP3/Timeless axis may be a potential therapeutic strategy against LUAD.
Insights
Specificity protein 3 (SP3) upregulates Timeless in lung adenocarcinoma (LUAD), promoting cancer cell proliferation. Targeting the SP3/Timeless axis offers a potential therapeutic strategy for LUAD patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Timeless is implicated in replication checkpoints and human malignancies.
- The interaction between Specificity protein 3 (SP3) and Timeless in lung adenocarcinoma (LUAD) remains uninvestigated.
Purpose of the Study:
- To investigate the role of Timeless in LUAD.
- To explore the regulatory mechanism of Timeless transcription by SP3 in LUAD.
Main Methods:
- Analysis of Timeless expression and clinical significance in LUAD using TCGA data.
- Lentivirus-mediated Timeless knockdown in A549 cells to assess proliferation and pemetrexed (PEM) resistance.
- Identification of transcription factors binding to the Timeless promoter via DNA pull-down and HPLC-MS/MS, followed by KEGG pathway analysis.
- Dual-luciferase reporter assay to confirm SP3's role in Timeless transcription.
Main Results:
- Timeless is overexpressed in LUAD and serves as a potential diagnostic/prognostic biomarker.
- Timeless knockdown reduced LUAD cell viability, proliferation, and sensitized PEM-resistant cells to PEM.
- SP3 was identified as a transcription factor promoting Timeless transcription through binding to the F2 fragment of its promoter.
Conclusions:
- SP3-mediated upregulation of Timeless promotes LUAD cell proliferation.
- The SP3/Timeless axis represents a potential therapeutic target for LUAD.
More Related Videos
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
Related Concept Videos
Abnormal Proliferation
TGF - β Signaling Pathway